MRK
Merck & Company IncNYSEHEALTHCAREDRUG MANUFACTURERS - GENERAL
Key Statistics
Market Cap
$295.39B
P/E Ratio
33.69
EPS
$3.55
Beta
0.22
52W High
$124.22
52W Low
$74.71
50-Day MA
$116.19
200-Day MA
$104.10
Dividend Yield
2.74%
Profit Margin
13.60%
Forward P/E
23.64
PEG Ratio
5.56
About Merck & Company Inc
Merck & Co. is an American multinational pharmaceutical company headquartered in Kenilworth, New Jersey. It is named after the Merck family, which set up Merck Group in Germany in 1668.
Fundamentals
| Revenue (TTM) | $65.77B |
| Gross Profit (TTM) | $50.46B |
| EBITDA | $29.52B |
| Operating Margin | 38.60% |
| Return on Equity | 18.90% |
| Return on Assets | 12.60% |
| Revenue/Share (TTM) | $26.42 |
| Book Value | $18.58 |
| Price-to-Book | 6.44 |
| Price-to-Sales (TTM) | 4.49 |
| EV/Revenue | 5.15 |
| EV/EBITDA | 17.46 |
| Quarterly Earnings Growth (YoY) | -19.30% |
| Quarterly Revenue Growth (YoY) | 4.90% |
| Shares Outstanding | $2.47B |
| Float | $2.47B |
| % Insiders | 0.06% |
| % Institutions | 82.30% |
Historical Volatility
HV 10-Day
31.27%
HV 20-Day
33.28%
HV 30-Day
29.09%
HV 60-Day
27.37%
HV Rank
70.2%
Volatility is currently expanding
Analyst Ratings
Consensus ($129.74 target)
4
Strong Buy15
Buy10
HoldMore HEALTHCARE Stocks
Data last updated: 6/10/2026